Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Revenue (2016 - 2026)

Biomerica's Revenue history spans 17 years, with the latest figure at $987000.0 for Q1 2026.

  • On a quarterly basis, Revenue fell 11.8% to $987000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $4.3 million, a 23.81% decrease, with the full-year FY2025 number at $5.3 million, down 1.92% from a year prior.
  • Revenue hit $987000.0 in Q1 2026 for Biomerica, down from $1.2 million in the prior quarter.
  • Over the last five years, Revenue for BMRA hit a ceiling of $7.7 million in Q1 2022 and a floor of $749000.0 in Q2 2025.
  • Historically, Revenue has averaged $1.9 million across 5 years, with a median of $1.4 million in 2025.
  • Biggest five-year swings in Revenue: soared 403.02% in 2022 and later plummeted 85.5% in 2023.
  • Tracing BMRA's Revenue over 5 years: stood at $1.5 million in 2022, then rose by 5.74% to $1.6 million in 2023, then increased by 4.4% to $1.6 million in 2024, then decreased by 26.04% to $1.2 million in 2025, then decreased by 18.43% to $987000.0 in 2026.
  • Business Quant data shows Revenue for BMRA at $987000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.